سعر كلافيموكس Clavimox‏ 228مجم/5مل معلق 70 مل 228.5mg/5ml 2026

Clavimox 228.5 mg/5 ml powder for oral suspension 70 ml (amoxicillin + clavulanic acid), powder for oral suspension by Pharco Pharmaceuticals.

• Contraindicated with a history of serious hypersensitivity reactions (e.g. anaphylaxis, Stevens-Johnson syndrome) to amoxicillin, clavulanate or other beta-lactams (penicillins, cephalosporins).International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Contraindicated with a previous history of cholestatic jaundice/hepatic dysfunction associated with amoxicillin/clavulanate.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Serious, including fatal, hypersensitivity reactions: discontinue if a reaction occurs; severe cutaneous adverse reactions, hepatic dysfunction and Clostridioides difficile-associated diarrhoea have been reported.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Published epidemiologic studies and pharmacovigilance over decades have not established a drug-associated risk of major birth defects, miscarriage or adverse maternal outcomes; a study in PPROM reported increased necrotising enterocolitis risk in neonates with prophylactic use.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Amoxicillin: Bactericidal beta-lactam that inhibits bacterial cell-wall biosynthesis during active multiplication; inactivated by beta-lactamases (US label, section 12.4).
• Clavulanic acid: Beta-lactam that inactivates some beta-lactamases, protecting amoxicillin from degradation.